IL-17 enhancement of the IL-6 signaling cascade in astrocytes

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4898-4906

  Ma, Xiangyu ^a,b   Reynolds, Stephanie L ^a   Baker, Brandi J ^a   Li, Xingang ^b   Benveniste, Etty N ^a   Qin, Hongwei ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P300; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3; SYNAPTOTAGMIN I; IL17A PROTEIN, MOUSE; INTERLEUKIN 6 RECEPTOR; RECOMBINANT PROTEIN; SOCS3 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ACETYLATION; ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE DELETION; GENETIC TRANSCRIPTION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ASTROCYTES; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 77954532398     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000142     Document Type: Article

References (63)

1. Iadecola, C., and M. Nedergaard. 2007. Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10: 1369-1376.
2. Dong, Y., and E. N. Benveniste. 2001. Immune function of astrocytes. Glia 36: 180-190.
3. Sofroniew, M. V. 2009. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32: 638-647.
4. Williams, A., G. Piaton, and C. Lubetzki. 2007. Astrocytes - friends or foes in multiple sclerosis? Glia 55: 1300-1312.
5. Allen, N. J., and B. A. Barres. 2009. Neuroscience: Glia - more than just brain glue. Nature 457: 675-677.
6. Wang, D. D., and A. Bordey. 2008. The astrocyte odyssey. Prog. Neurobiol. 86: 342-367.
7. Gabay, C. 2006. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8(Suppl 2): S3.
8. Scheller, J., N. Ohnesorge, and S. Rose-John. 2006. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand. J. Immunol. 63: 321-329.
9. De Keyser, J., J. P. Mostert, and M. W. Koch. 2008. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 267: 3-16.
10. Van Wagoner, N. J., J. W. Oh, P. Repovic, and E. N. Benveniste. 1999. Interleukin- 6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J. Neurosci. 19: 5236-5244.
11. Benveniste, E. N., S. M. Sparacio, J. G. Norris, H. E. Grenett, and G. M. Fuller. 1990. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30: 201-212.
12. Benveniste, E. N., J. Kwon, W. J. Chung, J. Sampson, K. Pandya, and L. P. Tang. 1994. Differential modulation of astrocyte cytokine gene expression by TGFbeta. J. Immunol. 153: 5210-5221.
13. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
14. Miossec, P., T. Korn, and V. K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361: 888-898.
15. Lohr, J., B. Knoechel, J. J.Wang, A. V. Villarino, and A. K. Abbas. 2006. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 203: 2785-2791.
16. Flierl, M. A., D. Rittirsch, H. Gao, L. M. Hoesel, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, J. L. Ferrara, and P. A.Ward. 2008. Adverse functions of IL-17A in experimental sepsis. FASEB J. 22: 2198-2205.
17. Graber, J. J., S. R. Allie, K. M. Mullen, M. V. Jones, T. Wang, C. Krishnan, A. I. Kaplin, A. Nath, D. A. Kerr, and P. A. Calabresi. 2008. Interleukin-17 in transverse myelitis and multiple sclerosis. J. Neuroimmunol. 196: 124-132.
18. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
19. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
20. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
21. Ogura, H., M. Murakami, Y. Okuyama, M. Tsuruoka, C. Kitabayashi, M. Kanamoto, M. Nishihara, Y. Iwakura, and T. Hirano. 2008. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29: 628-636.
22. Inoue, D., M. Numasaki, M.Watanabe, H. Kubo, T. Sasaki, H. Yasuda, M. Yamaya, and H. Sasaki. 2006. IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. Biochem. Biophys.Res.Commun. 347: 852-858.
23. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
24. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177: 36-39.
25. Trajkovic, V., S. Stosic-Grujicic, T. Samardzic, M. Markovic, D. Miljkovic, Z. Ramic, and M. Mostarica Stojkovic. 2001. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 119: 183-191. (Pubitemid 32918325)
26. Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.
27. Baker, B. J., L. N. Akhtar, and E. N. Benveniste. 2009. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 30: 392-400.
28. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465.
29. Baker, B. J., H. Qin, and E. N. Benveniste. 2008. Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes. Glia 56: 1250-1262.
30. Qin, H., C. A. Wilson, K. L. Roberts, B. J. Baker, X. Zhao, and E. N. Benveniste. 2006. IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J. Immunol. 177: 7761-7771.
31. Pauli, E. K., M. Schmolke, T. Wolff, D. Viemann, J. Roth, J. G. Bode, and S. Ludwig. 2008. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog. 4: e1000196.
32. Cohney, S. J., D. Sanden, N. A. Cacalano, A. Yoshimura, A. Mui, T. S. Migone, and J. A. Johnston. 1999. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 19: 4980-4988.
33. Baetz, A., M. Frey, K. Heeg, and A. H. Dalpke. 2004. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279: 54708-54715.
34. Bellezza, I., H. Neuwirt, C. Nemes, I. T. Cavarretta, M. Puhr, H. Steiner, A. Minelli, G. Bartsch, F. Offner, A. Hobisch, et al. 2006. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer. Am. J. Pathol. 169: 2199-2208.
35. Cacalano, N. A., D. Sanden, and J. A. Johnston. 2001. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3: 460-465.
36. Qin, H., L.Wang, T. Feng, C. O. Elson, S. A. Niyongere, S. J. Lee, S. L. Reynolds, C. T. Weaver, K. Roarty, R. Serra, et al. 2009. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J. Immunol. 183: 97-105.
37. Croker, B. A., D. L. Krebs, J. G. Zhang, S. Wormald, T. A. Willson, E. G. Stanley, L. Robb, C. J. Greenhalgh, I. Förster, B. E. Clausen, et al. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4: 540-545.
38. Qin, H., S. A. Niyongere, S. J. Lee, B. J. Baker, and E. N. Benveniste. 2008. Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J. Immunol. 181: 3167-3176.
39. Qin, H.,K. L.Roberts, S. A. Niyongere,Y. Cong, C. O. Elson, and E. N. Benveniste. 2007. Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J. Immunol. 179: 5966-5976.
40. Atkinson, G. P., S. E. Nozell, D. K. Harrison, M. S. Stonecypher, D. Chen, and E. N. Benveniste. 2009. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28: 3735-3745.
41. Qin, H., C. A. Wilson, S. J. Lee, and E. N. Benveniste. 2006. IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. FASEB J. 20: 985-987.
42. Das Sarma, J., B. Ciric, R. Marek, S. Sadhukhan, M. L. Caruso, J. Shafagh, D. C. Fitzgerald, K. S. Shindler, and A. Rostami. 2009. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. J. Neuroinflammation 6: 14.
43. Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179: 4135-4141.
44. Lee, J. W., P. Wang, M. G. Kattah, S. Youssef, L. Steinman, K. DeFea, and D. S. Straus. 2008. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J. Immunol. 181: 6536-6545.
45. Horn, P. J., and C. L. Peterson. 2002. Molecular biology. Chromatin higher order folding - wrapping up transcription. Science 297: 1824-1827.
46. Berger, S. L. 2001. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene 20: 3007-3013.
47. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14: 1553-1577.
48. Lu, H., J. Y. Wu, T. Kudo, T. Ohno, D. Y. Graham, and Y. Yamaoka. 2005. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol. Biol. Cell 16: 4954-4966.
49. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204: 2803-2812.
50. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
51. Harper, E. G., C. Guo, H. Rizzo, J. V. Lillis, S. E. Kurtz, I. Skorcheva, D. Purdy, E. Fitch, M. Iordanov, and A. Blauvelt. 2009. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 129: 2175-2183.
52. Van Wagoner, N. J., and E. N. Benveniste. 1999. Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100: 124-139.
53. Iwakura, Y., S. Nakae, S. Saijo, and H. Ishigame. 2008. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226: 57-79.
54. Wu, H. Y., E. M. Center, G. C. Tsokos, and H. L. Weiner. 2009. Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells. Lupus 18: 586-596.
55. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
56. Tompkins, S. M., and S. D. Miller. 2002. An array of possibilities for multiple sclerosis. Nat. Med. 8: 451-453.
57. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous system-in-filtrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155.
58. Montes, M., X. Zhang, L. Berthelot, D. A. Laplaud, S. Brouard, J. Jin, S. Rogan, D. Armao, V. Jewells, J. P. Soulillou, and S. Markovic-Plese. 2009. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin. Immunol. 130: 133-144.
59. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573.
60. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
61. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
62. Haak, S., A. L. Croxford, K. Kreymborg, F. L. Heppner, S. Pouly, B. Becher, and A. Waisman. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119: 61-69.
63. Steinman, L. 2010. Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat. Immunol. 11: 41-44.